Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Exp Eye Res ; 215: 108904, 2022 02.
Article in English | MEDLINE | ID: mdl-34954205

ABSTRACT

PAX6 haploinsufficiency related aniridia is characterized by disorder of limbal epithelial cells (LECs) and aniridia related keratopathy. In the limbal epithelial cells of aniridia patients, deregulated retinoic acid (RA) signaling components were identified. We aimed to visualize differentiation marker and RA signaling component expression in LECs, combining a differentiation triggering growth condition with a small interfering RNA (siRNA) based aniridia cell model (PAX6 knock down). Primary LECs were isolated from corneoscleral rims of healthy donors and cultured in serum free low Ca2+ medium (KSFM) and in KSFM supplemented with 0.9 mmol/L Ca2+. In addition, LECs were treated with siRNA against PAX6. DSG1, PAX6, KRT12, KRT 3, ADH7, RDH10, ALDH1A1, ALDH3A1, STRA6, CYP1B1, RBP1, CRABP2, FABP5, PPARG, VEGFA and ELOVL7 expression was determined using qPCR and western blot. DSG1, FABP5, ADH7, ALDH1A1, RBP1, CRABP2 and PAX6 mRNA and FABP5 protein expression increased (p ≤ 0.03), PPARG, CYP1B1 mRNA expression decreased (p ≤ 0.0003) and DSG1 protein expression was only visible after Ca2+ supplementation. After PAX6 knock down and Ca2+ supplementation, ADH7 and ALDH1A1 mRNA and DSG1 and FABP5 protein expression decreased (p ≤ 0.04), compared to Ca2+ supplementation alone. Using our cell model, with Ca2+ supplementation and PAX6 knockdown with siRNA treatment against PAX6, we provide evidence that haploinsufficiency of the master regulatory gene PAX6 contributes to differentiation defect in the corneal epithelium through alterations of RA signalling. Upon PAX6 knockdown, DSG1 differentiation marker and FABP5 RA signaling component mRNA expression decreases. A similar effect becomes apparent at protein level though differentiation triggering Ca2+ supplementation in the siRNA-based aniridia cell model. Expression data from this cell model and from our siRNA aniridia cell model strongly indicate that FABP5 expression is PAX6 dependent. These new findings may lead to a better understanding of differentiation processes in LECs and are able to explain the insufficient cell function in AAK.


Subject(s)
Aniridia , Desmoglein 1 , Fatty Acid-Binding Proteins , PAX6 Transcription Factor , Aniridia/genetics , Antigens, Differentiation , Desmoglein 1/biosynthesis , Desmoglein 1/genetics , Epithelial Cells/metabolism , Fatty Acid-Binding Proteins/biosynthesis , Fatty Acid-Binding Proteins/genetics , Fatty Acid-Binding Proteins/metabolism , Humans , PAX6 Transcription Factor/genetics , PAX6 Transcription Factor/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Tretinoin/metabolism
2.
Hum Pathol ; 43(10): 1745-54, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22521077

ABSTRACT

Gastroesophageal reflux disease is associated with impaired epithelial barrier function and abnormal expression of proteins forming cell-cell contacts by tight junctions and desmosomes in distal esophageal squamous mucosa. Although gastroesophageal reflux disease and Helicobacter pylori are both associated with chronic inflammation of the adjacent cardia mucosa, it is not known whether these lead to derangements of the desmosomal complexes. Here, we assessed the expression of 4 proteins (plakoglobin and desmoglein 1, 2, and 3) forming epithelial desmosomal complexes by quantitative reverse transcription polymerase chain reaction and immunohistochemistry in biopsies from 67 patients with gastroesophageal reflux disease and 23 gastroesophageal reflux disease-negative controls. Plakoglobin and desmoglein 2 were ubiquitously expressed in all samples, whereas desmoglein 1 and 3 were not expressed in cardia mucosa. Gastroesophageal reflux disease was specifically associated with elevated transcript levels of desmoglein 2 and plakoglobin. These were significantly increased from 2.0- to 2.7-fold in patients with gastroesophageal reflux disease compared with controls (P < .01), and significantly increased immunohistochemical scores for both proteins were observed (P < .05) as well. The combined presence of gastroesophageal reflux disease and Helicobacter pylori infection had no additional effect on desmosomal gene expression. Taken together, the up-regulation of plakoglobin and desmoglein 2 in cardia mucosa of patients with gastroesophageal reflux disease supports the concept that the "transition zone" between distal esophagus and proximal stomach is affected by gastroesophageal reflux disease as well, and architectural and molecular changes in the desmosomal compartment contribute to the pathogenesis of gastroesophageal reflux disease in the cardia mucosa.


Subject(s)
Desmosomes/metabolism , Gastroesophageal Reflux/metabolism , Gastroesophageal Reflux/microbiology , Helicobacter Infections/metabolism , Adult , Aged , Cardia/metabolism , Cardia/microbiology , Cardia/pathology , Desmoglein 1/analysis , Desmoglein 1/biosynthesis , Desmoglein 2/analysis , Desmoglein 2/biosynthesis , Desmoglein 3/analysis , Desmoglein 3/biosynthesis , Female , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Helicobacter Infections/complications , Helicobacter Infections/pathology , Helicobacter pylori , Humans , Immunohistochemistry , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Up-Regulation , Young Adult , gamma Catenin/analysis , gamma Catenin/biosynthesis
3.
Article in Chinese | MEDLINE | ID: mdl-19594018

ABSTRACT

OBJECTIVE: To compare the effects of two different cryoprotectants on human desmoglein 1 (Dsg 1), and to provide experimental basis for the optimization of cryoprotectant. METHODS: Five donated thin split-thickness skin grafts were used, and the experiment was conducted within 4 hours after skin grafts harvest. The skin grafts were divided into 3 groups: group A (n = 2) in which skin grafts were immersed in 0.5 mol/L trehalose/DMSO; group B (n = 2) in which skin grafts were immersed in DMSO/propanediol; group C (n = 1) in which fresh skin graft received no further treatment. Groups A and B were stored in -196 degree C liquid nitrogen for 7 and 21 days, respectively, and then underwent experiment. Immunohistochemistry staining observation was performed on each group, RT-PCR method was used to detect the expression of Dsg 1 in skin. RESULTS: The immunohistochemistry staining showed that the protein in groups A and B was stained brown-yellow and distributed evenly 7 days after cryopreservation; the expression signal of epidermal basal cell was similar to that of group C; absorbance (A) value of groups A, B and C was 0.285 +/- 0.006, 0.284 +/- 0.004 and 0.287 +/- 0.008, respectively, suggesting there was no significant difference between groups A and B and group C (P > 0.05). At 21 days after cryopreservation, the expression of positive cells in group B decreased; no obvious decrease was observed in group A, A value of groups A and B was 0.282 +/- 0.004 and 0.275 +/- 0.005, respectively, indicating there was a significant difference between group B and groups A and C (P < 0.05). RT-PCR detection showed that A value of groups A and B at 7 days after cryopreservation was 0.810 +/- 0.012 and 0.803 +/- 0.008, respectively; A value of groups A and B at 21 days after cryopreservation was 0.806 +/- 0.008 and 0.782 +/- 0.013, respectively; and the A value of group C was 0.814 +/- 0.012, indicating there was significant difference between group B and groups A and C at 21 days after cryopreservation (p < 0.05), and no significant differences among groups were noted at other time points (P > 0.05). CONCLUSION: Trehalose/DMSO is better than traditional cryoprotectant DMSO/propanediol in protecting Dsg 1 of human skin.


Subject(s)
Cryoprotective Agents/pharmacology , Desmoglein 1/biosynthesis , Skin/drug effects , Skin/metabolism , Graft Survival , Humans , Surgical Flaps , Tissue Culture Techniques , Trehalose/pharmacology
4.
Pathology ; 40(6): 611-6, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18752129

ABSTRACT

AIMS: Mucosal squamous cell carcinomas are the most common head and neck malignancies. We hypothesised that over-expression of intracellular signalling proteins and decreased expression of desmoglein molecules would be associated with aggressive tumour behaviour in patients with head and neck squamous cell carcinoma. METHODS: Seventy-eight cases of head and neck squamous cell carcinoma were immunohistochemically stained for desmoglein 1, desmoglein 2, desmoglein 3, p53, bcl-2, vimentin, cyclin D1, p16, p21, p27, E-cadherin, and E2F-1 in paraffin-embedded tissue blocks in a microarray. RESULTS: The disease-specific survival was 56% at 5 years and 49% at 10 years. Expression of the desmoglein isotypes correlated positively with each other except for desmoglein 2 and desmoglein 3, which did not show a significant correlation. Desmoglein 1 and E-cadherin expression also correlated. On univariate analysis, only expression of desmoglein 1 correlated with patient outcome; lack of expression of desmoglein 1 was associated with a significantly worse disease-specific survival (p = 0.035). Hierarchical clustering analysis identified a subgroup of three patients with an immunophenotype distinct from the other tumours, characterised by co-expression of p16, p27, E2F-1 and bcl-2. Further statistical analysis of the prognostic significance of this small subgroup was not possible, but these three patients are alive and well. CONCLUSIONS: Decreased expression of desmoglein 1 is associated with a worse prognosis in head and neck squamous cell carcinoma patients. Examination of an extended panel of immunomarkers revealed a rare subtype of squamous cell carcinoma characterised by the expression of multiple proliferation-associated markers and the anti-apoptotic protein, bcl-2; determination of the prognostic significance of this subgroup will require study of a larger case series.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Desmoglein 1/biosynthesis , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/pathology , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/mortality , Cluster Analysis , Head and Neck Neoplasms/mortality , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Prognosis , Tissue Array Analysis
5.
EMBO J ; 27(6): 886-97, 2008 Mar 19.
Article in English | MEDLINE | ID: mdl-18288204

ABSTRACT

In Drosophila, the grainy head (grh) gene plays a range of key developmental roles through the regulation of members of the cadherin gene family. We now report that mice lacking the grh homologue grainy head-like 1 (Grhl1) exhibit hair and skin phenotypes consistent with a reduction in expression of the genes encoding the desmosomal cadherin, desmoglein 1 (Dsg1). Grhl1-null mice show an initial delay in coat growth, and older mice exhibit hair loss as a result of poor anchoring of the hair shaft in the follicle. The mice also develop palmoplantar keratoderma, analogous to humans with DSG1 mutations. Sequence analysis, DNA binding, and chromatin immunoprecipitation experiments demonstrate that the human and mouse Dsg1 promoters are direct targets of GRHL1. Ultrastructural analysis reveals reduced numbers of abnormal desmosomes in the interfollicular epidermis. These findings establish GRHL1 as an important regulator of the Dsg1 genes in the context of hair anchorage and epidermal differentiation, and suggest that cadherin family genes are key targets of the grainy head-like genes across 700 million years of evolution.


Subject(s)
Desmosomal Cadherins/genetics , Desmosomes/genetics , Gene Expression Regulation/physiology , Repressor Proteins/genetics , Animals , Cell Differentiation/genetics , Desmoglein 1/biosynthesis , Desmoglein 1/genetics , Desmosomal Cadherins/antagonists & inhibitors , Desmosomal Cadherins/biosynthesis , Desmosomes/metabolism , Hair/abnormalities , Hair Follicle/embryology , Hair Follicle/metabolism , Mice , Mice, Knockout , Repressor Proteins/antagonists & inhibitors , Repressor Proteins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...